Elcelyx Therapeutics
San Diego
California
United States
15 articles about Elcelyx Therapeutics
-
Elcelyx Therapeutics Reports Positive Results In Phase 2b Study Of Metformin Delayed Release In Type 2 Diabetes
11/10/2016
-
Elcelyx Therapeutics Elects Sandy Mahatme To Board Of Directors
10/12/2016
-
Elcelyx Therapeutics Completes Enrollment In Phase 2b Clinical Trial Of Metformin Delayed Release For Type 2 Diabetes
5/25/2016
-
SoCal's Elcelyx Therapeutics Reels in $40 Million
10/1/2015
-
Elcelyx Therapeutics Announces Positive Results in Phase 2b Study of NewMet in Type 2 Diabetes
10/21/2013
-
Elcelyx Therapeutics to Present Clinical Data on NewMet in Type 2 Diabetes at the 49th Annual European Association for the Study of Diabetes Meeting
9/17/2013
-
NaZura BioHealth Spun-Out From Elcelyx Therapeutics to Advance Lovidia for Weight Management
9/4/2013
-
Elcelyx Therapeutics' NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
9/4/2013
-
Elcelyx Therapeutics' Study Shows NewMet Has Better Glucose-Lowering Effects Than Metformin
6/24/2013
-
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions
6/17/2013
-
Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes
5/20/2013
-
Elcelyx Therapeutics Closes on $20 Million to Advance Appetite-Control Compounds
2/14/2013
-
Elcelyx Therapeutics Raises $4 Million
8/13/2012
-
Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
8/13/2012
-
Startup Elcelyx Therapeutics Raises $1.2 Million
3/19/2010